Health ❯ Endocrinology

Diabetes

Type 2 Diabetes GLP-1 Receptor Agonists Kidney Complications Hormonal Regulation Beta-Cell Function Gestational Diabetes Complications Medication GLP-1 Agonists Treatment Options

10 ARTICLES

2w ago

Lilly’s Retatrutide Outperforms Ozempic in Late‑Stage Diabetes Trial

Topline company data show larger A1c reductions with roughly double the percent weight loss versus Ozempic, prompting Lilly to plan an early‑2027 FDA filing.

10 ARTICLES

2mo ago

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

5 ARTICLES

8mo ago

Most Weight Lost on GLP-1 Drugs Returns After Stopping, New Analysis Finds

4 ARTICLES

last yr.

Brown Fat Protein Neuritin 1 Boosts Energy Burning in Animals as New Obesity Target

3 ARTICLES

last yr.

Elderly Drivers with Diabetes at Risk of Losing Licences, Safety Group Says

4 ARTICLES

last yr.

Study Quantifies Link Between Maternal Diabetes and Neurodevelopmental Risks in Children

10 ARTICLES

last yr.

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

6 ARTICLES

last yr.

Weight-Loss Injections Linked to Increased Fertility and 'Ozempic Babies'

3 ARTICLES

2y ago

Low-Carb Diet Shows Promise in Improving Beta-Cell Function for Type 2 Diabetics

7 ARTICLES

2y ago

Sea Snail Venom Offers New Hope for Diabetes Treatment